DE69205579D1 - Virushemmende pharmazeutische zubereitungen zur vaginalen verabreichung. - Google Patents

Virushemmende pharmazeutische zubereitungen zur vaginalen verabreichung.

Info

Publication number
DE69205579D1
DE69205579D1 DE69205579T DE69205579T DE69205579D1 DE 69205579 D1 DE69205579 D1 DE 69205579D1 DE 69205579 T DE69205579 T DE 69205579T DE 69205579 T DE69205579 T DE 69205579T DE 69205579 D1 DE69205579 D1 DE 69205579D1
Authority
DE
Germany
Prior art keywords
virus
pharmaceutical preparations
vaginal administration
inhibiting pharmaceutical
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69205579T
Other languages
English (en)
Other versions
DE69205579T2 (de
Inventor
Ubaldo Conte
Lauretta Maggi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
L C PHARCHEM Ltd
Original Assignee
L C PHARCHEM Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L C PHARCHEM Ltd filed Critical L C PHARCHEM Ltd
Application granted granted Critical
Publication of DE69205579D1 publication Critical patent/DE69205579D1/de
Publication of DE69205579T2 publication Critical patent/DE69205579T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69205579T 1991-07-26 1992-07-20 Virushemmende pharmazeutische zubereitungen zur vaginalen verabreichung. Expired - Fee Related DE69205579T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI912071A IT1251114B (it) 1991-07-26 1991-07-26 Forme farmaceutiche antivirali per applicazione vaginale
PCT/EP1992/001655 WO1993002662A1 (en) 1991-07-26 1992-07-20 Antiviral pharmaceutical compositions for vaginal administration
CN92111077A CN1082894A (zh) 1991-07-26 1992-08-24 阴道给药的抗病毒药物组合物

Publications (2)

Publication Number Publication Date
DE69205579D1 true DE69205579D1 (de) 1995-11-23
DE69205579T2 DE69205579T2 (de) 1996-04-04

Family

ID=36790864

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69205579T Expired - Fee Related DE69205579T2 (de) 1991-07-26 1992-07-20 Virushemmende pharmazeutische zubereitungen zur vaginalen verabreichung.

Country Status (10)

Country Link
EP (1) EP0596935B1 (de)
JP (1) JPH06509348A (de)
CN (1) CN1082894A (de)
AT (1) ATE129149T1 (de)
AU (1) AU2345492A (de)
CA (1) CA2114216A1 (de)
DE (1) DE69205579T2 (de)
DK (1) DK0596935T3 (de)
IT (1) IT1251114B (de)
WO (1) WO1993002662A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4139883A1 (de) * 1991-11-29 1993-06-03 Michael Prof Dr Dittgen Verfahren zur herstellung bioadhaesiver arzneimittel
FR2710265B1 (fr) * 1993-09-22 1995-10-20 Adir Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
DE4404011A1 (de) * 1994-02-09 1995-08-10 Jenapharm Gmbh Neue, adhäsiv wirkende Zubereitungen für mit Flüssigkeit benetzte Oberflächen, Verfahren und Vorrichtung zur Erfassung der Adhäsionszeit diesbezüglicher Zubereitungen
UA74168C2 (uk) * 1999-10-05 2005-11-15 Коламбіа Леборетеріс (Бермуда) Лімітед Лікування ендометріозу або безпліддя, або покращення плідності та застосування бета-адренергічного агоніста для виробництва лікарського засобу
US6818672B1 (en) 1999-10-05 2004-11-16 Columbia Laboratories, Inc. Treating endometriosis or infertility, or improving fertility
BR0007360A (pt) * 1999-12-23 2001-08-14 Johnson & Johnson Composição de liberação controlada
JP2001240558A (ja) * 2000-02-29 2001-09-04 Nippon Suisan Kaisha Ltd 多価不飽和脂肪酸を経粘膜吸収促進剤として含有する固形製剤。
EP1318790A4 (de) * 2000-09-19 2006-02-01 Cima Labs Inc Pharmazeutische zusammensetzungen zur rektalen und vaginalen verabreichung
BRPI0414500A (pt) * 2003-09-19 2006-11-07 Drugtech Corp formulação farmacêutica composição para tratar uma infecção vaginal, e, métodos para tratar uma infecção vaginal, para estabilizar uma formulação de clindamicina, para tratar ou prevenir uma recorrência de uma infecção vaginal em uma paciente e para tratar condições vaginais
AU2004311879B2 (en) 2003-12-31 2010-08-05 Cima Labs Inc. Effervescent oral opiate dosage form
EP1708686B1 (de) 2003-12-31 2011-02-16 Cima Labs Inc. Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung
EP2662086A1 (de) * 2012-05-08 2013-11-13 Progressare Medinvest B.V. Zusammensetzung für die Behandlung oder Vorbeugung von Infektionen des Urintrakts und Dosierform

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3388041A (en) * 1964-01-27 1968-06-11 Richardson Merrell Inc High dosage sustained release tablet
JPS52156913A (en) * 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
JPS5562012A (en) * 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
JPS58152809A (ja) * 1982-03-05 1983-09-10 Eisai Co Ltd 安定な発泡性「膣」坐剤
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
IT1187750B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di compresse,anche a rilascio prolungato,di iscsorbide-5-mononitrato stabilizzato e formulazioni cosi' ottenute
IT1213323B (it) * 1986-08-07 1989-12-20 Crinos Industria Farmaco Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida
NZ222698A (en) * 1987-01-08 1990-02-26 Squibb & Sons Inc Bioadhesive suppository formulations comprising a medicament, water, a hydrocolloid and low melting point base
US4983393A (en) * 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release

Also Published As

Publication number Publication date
DE69205579T2 (de) 1996-04-04
CA2114216A1 (en) 1993-02-18
CN1082894A (zh) 1994-03-02
IT1251114B (it) 1995-05-04
JPH06509348A (ja) 1994-10-20
AU2345492A (en) 1993-03-02
ATE129149T1 (de) 1995-11-15
ITMI912071A0 (it) 1991-07-26
DK0596935T3 (da) 1996-01-22
WO1993002662A1 (en) 1993-02-18
EP0596935A1 (de) 1994-05-18
EP0596935B1 (de) 1995-10-18
ITMI912071A1 (it) 1993-01-27

Similar Documents

Publication Publication Date Title
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
DE69231965T2 (de) Pharmazeutische formulierungen
DE69613463T2 (de) Filmbildende pharmazeutische zusammensetzungen zur transdermalen verabreichung
IT1243541B (it) Dispositivo di somministrazione in particolare di sostanza farmaceutica
ES2097155T3 (es) Forma de dosificacion efervescente y metodo de administracion.
ES2061799T3 (es) Nuevo preparado medicamentoso y procedimiento para su preparacion.
ITRM910922A1 (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
CY1107838T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
IT8619675A0 (it) Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale.
ATE129149T1 (de) Virushemmende pharmazeutische zubereitungen zur vaginalen verabreichung.
SE9301171D0 (sv) Pharmaceutical composition containing lipophilic drugs
DE69212879D1 (de) Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren
DE69015842D1 (de) Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen.
ATE292453T1 (de) Antivirale arznei
DE69006094D1 (de) Pharmazeutische Zusammensetzungen.
IT8820073A0 (it) Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
ES2188582T3 (es) El uso de ranitidina-citrato de bismuto en combinacion con claritromicina o claritromicina y tetraciclina en la fabricacion de un medicamento para tratar trastornos gastrointestinales.
HRP20010684B1 (en) Directly compressible matrix for controlled release of single daily doses of clarithromycin
DE59005281D1 (de) Pharmazeutische präparate.
DE69004532D1 (de) Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen.
IT1256623B (it) Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche
HRP20000781B1 (en) Effervescent preparations
SE0001916D0 (sv) Novel formulation
YU44392A (sh) Postupak za dobijanje farmaceutske formulacije diritromicina
DE60103276D1 (de) Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee